PharmiWeb.com - Global Pharma News & Resources
28-Sep-2018

Peak Health Announces Results from Studies of ImmunAG™ and Cannabidiol (CBD) for Reducing Valvular Interstitial Cell Calcification (VIC) in Human Heart

LOS GATOS, Calif., Sept. 26, 2018 /PRNewswire/ -- Peak Health, a leading nutrition and fitness company dedicated to improving human health, announced results from two studies exploring the effects of cannabidiol (CBD) and its own ImmunAG™ product as a treatment for valvular interstitial cell (VIC) calcification. The tests revealed that ImmunAG™ reduced calcification more than CBD at every concentration.

Published today in the Journal of Medical Phyto Research, both studies were conducted to determine the effects of different concentrations of CBD and ImmunAG by isolating calcified VICs and testing treatment concentrations of 5,10, 25, 40, and 100 mg. Valvular interstitial cells (VICs) are integral to heart valve homeostasis and structural leaflet integrity. Calcification of VICs leads to dangerous diseases including calcific aortic valve disease. Findings revealed that more bioactive CBD in greater concentration greatly reduces VIC when combined with B-Caryophyllene and a-Humulene.

"The research demonstrated that a combination of high bioactivity CBD, BCP, and HUM reduces VIC calcification more than high bioactivity CBD alone," said Donish Cushing, lead author of both studies. "As phytoceutical approaches to medicine continue to gain traction, an uncovering of the ways that each of these properties interact will constitute an exciting new frontier for science."

Cushing continued, "It remains to be seen whether possible synergistic effects afforded by this combination of compounds extends beyond VIC calcification. CBD has been shown to have anxiolytic, antidepressant, antipsychotic, anticonvulsant, anti-nausea, antioxidant, anti-inflammatory, anti-arthritic, and anti-neoplastic properties."

Peak Health Center is a premier fitness and nutrition company in the United States. The company's founders, Dr. Avi Cohen and Dr. Bomi Joseph are dedicated to conducting research and studying the efficacy of plant compounds on human health. Dr. Joseph has a significant background in phytotherapy and has successfully developed a variety of phytoceutical products. The findings of this recent study are one of a series of studies being conducted by Peak Health and are intended to help people understand the value of phytoceuticals and better understand the new concept of "bioactivity" in CBD's potential health benefits.

For more information about Peak Health, please visit the company's website.

About Peak Health
Peak Health Center is a 501(c)(3), Not-For-Profit Corporation, based out of Los Gatos, CA. Its charter is to improve human health, with the least use of pharmaceutical drugs. Its researchers from around the globe are volunteering efforts to enhance our knowledge of endogenous health and phytotherapy. To learn more, please visit www.peakhealth.center.

Public Relations Contact:
Andrew Hard
CEO CMW Media
858.264.6600
Andrew.hard@cmwmedia.com
www.cmwmedia.com

Editor Details

Last Updated: 28-Sep-2018